Could flickering lights and sounds slow Alzheimer's? MIT launches home device trial

NCT ID NCT05655195

Recruiting now Disease control Sponsor: Massachusetts Institute of Technology Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a device that flashes light and plays sound at a specific frequency (40Hz) can help people with mild Alzheimer's. Sixty participants will use the device at home for an hour each day over six months. Researchers will check brain waves, memory, and blood markers to see if the stimulation slows the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GENUS device (light and sound stimulation at 40Hz)
What this could lead to: If it works, this could point toward a non-invasive, at-home treatment to slow Alzheimer's progression by reducing harmful brain proteins and improving memory.
What could go wrong: This is an early feasibility study with only 60 people. It may show no benefit, and side effects like headache or dizziness are possible. Results may not apply to all Alzheimer's patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Alzheimer disease 2 dementia early-onset autosomal dominant Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE ALZHEIMER DISEASE, EARLY ONSET ALZHEIMER DISEASE, LATE ONSET ALZHEIMER'S ALZHEIMER'S DISEASE ALZHEIMER'S DISEASE (INCL SUBTYPES)

Contacts and locations

Locations

Massachusetts Institute of Technology
RECRUITING

Cambridge, Massachusetts, 02142, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.